You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 263 No. 21, June 6, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communication
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Quality-Adjusted Life-Years

Ethical Implications for Physicians and Policymakers

John La Puma, MD; Edward F. Lawlor, PhD

JAMA. 1990;263(21):2917-2921.


Abstract

Quality-adjusted life-years have been used in economic analyses as a measure of health outcomes, one that reflects both lives saved and patients' valuations of quality of life in alternative health states. The concept of "cost per qualityadjusted life year" as a guideline for resource allocation is founded on six ethical assumptions: quality of life can be accurately measured and used, utilitarianism is acceptable, equity and efficiency are compatible, projections of community preferences can substitute for individual preferences, the old have less "capacity to benefit" than the young, and physicians will not use quality-adjusted life-years as clinical maxims. Quality-adjusted life-years signal two shifts in the locus of control and the nature of the clinical encounter: first, formal expressions of community preferences and societal usefulness would counterbalance patient autonomy, and second, formal tools of resource allocation and applied decision analysis would counterbalance the use of clinical judgment. These shifts reflect and reinforce a new financial ethos in medical decision making. Presently using quality-adjusted life-years for health policy decisions is problematic and speculative; using quality-adjusted life-years at the bedside is dangerous.

(JAMA. 1990;263:2917-2921)



Author Affiliations

From the Center for Clinical Ethics, Lutheran General Hospital, Park Ridge, III (Dr La Puma); and the School of Social Service Administration, the University of Chicago (Dr Lawlor).


Footnotes

The opinions expressed are those of the authors and do not necessarily reflect those of the supporting institutions.

Reprint requests to Center for Clinical Ethics, Lutheran General Hospital, 1775 Dempster St, Park Ridge, IL 60068 (Dr La Puma).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids
van Staa et al.
Rheumatology (Oxford) 2007;46:460-466.
ABSTRACT | FULL TEXT  

Cancer Care, Money, and the Value of Life: Whose Justice? Which Rationality?
Sulmasy
JCO 2007;25:217-222.
ABSTRACT | FULL TEXT  

Economic Evaluationin Orthopaedics
Bozic et al.
JBJS 2003;85:129-142.
FULL TEXT  

Economics of chronic heart failure
Berry et al.
Eur J Heart Fail 2001;3:283-291.
ABSTRACT | FULL TEXT  

Preference for Equity As a Framing Effect
Ubel et al.
Med Decis Making 2001;21:180-189.
ABSTRACT  

Initiating End-of-Life Discussions With Seriously Ill Patients: Addressing the "Elephant in the Room"
Quill
JAMA 2000;284:2502-2507.
ABSTRACT | FULL TEXT  

Quality of Life: Erosions and Opportunities Under Managed Care
Morreim
J Law Med Ethics 2000;28:144-158.
 

Health Values of Hospitalized Patients 80 Years or Older
Tsevat et al.
JAMA 1998;279:371-375.
ABSTRACT | FULL TEXT  

Competing Practice Guidelines: Using Cost-Effectiveness Analysis To Make Optimal Decisions
Granata and Hillman
ANN INTERN MED 1998;128:56-63.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of 6 and 12 Months of Interferon-{alpha} Therapy for Chronic Hepatitis C
Kim et al.
ANN INTERN MED 1997;127:866-874.
ABSTRACT | FULL TEXT  

Patient-assessed Health Outcomes in Chronic Lung Disease . What are They, How Do They Help Us, and Where Do We Go From Here?
CURTIS et al.
Am. J. Respir. Crit. Care Med. 1997;156:1032-1039.
FULL TEXT  

Health Values of the Seriously Ill
Tsevat et al.
ANN INTERN MED 1995;122:514-520.
ABSTRACT | FULL TEXT  

Anticipated Changes in the Doctor-Patient Relationship in the Managed Care and Managed Competition of the Health Security Act of 1993
Puma
Arch Fam Med 1994;3:665-671.
ABSTRACT  

Setting Limits in Clinical Medicine
Murphy et al.
Arch Intern Med 1994;154:505-512.
ABSTRACT  

Mechanical Ventilation for the Elderly Patient in Intensive Care: Incremental Charges and Benefits
Cohen et al.
JAMA 1993;269:1025-1029.
ABSTRACT  

Breast Cancer Screening for Elderly Women with and without Comorbid Conditions: A Decision Analysis Model
Mandelblatt et al.
ANN INTERN MED 1992;116:722-730.
ABSTRACT  

QALYs: Their Ethical Implications
Kaplan and Ganiats
JAMA 1990;264:2502-2503.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.